The drug regulator has cleared Serum Institute to begin Phase III trials for a 2-in-1 covid-flu vaccine while simultaneously approving an Omicron-specific booster, marking a transition toward seasonal ...
Rising omicron cases in Indian national capital region of Delhi caused the administration to declare a yellow alert on Tuesday. Among the businesses to be instantly affected are standalone cinemas and ...